Back

New evidence: First-line Cryoballoon ablation vs. antiarrhythmic drugs for paroxysmal AF.

31 August 2020 (18:52 - 19:09)
Organised by:
Congress Presentation Part of: Getting atrial fibrillation treatment right the first time Rhythm Control, Catheter Ablation Open Access ESC Congress 2020

About the speaker

Photo
Doctor Gian Battista Chierchia

Heart Rhythm Management Centre, Brussels (Belgium)

4 More presentations in this session

Presentation thumbnail
Introduction.
Doctor D. Packer (Salt Lake City, US)
Video
Presentation thumbnail
The latest ESC AF management guidelines and the vision for an optimal AF patient pathway.
Professor G. Hindricks (Berlin, DE)
Video
Presentation thumbnail
AF progression and the importance of early treatment for improving clinical outcomes.
Professor S. Willems (Hamburg, DE)
Video
Presentation thumbnail
Conclusions.
Doctor D. Packer (Salt Lake City, US)
Video

Access the full session

Session thumbnail
Getting atrial fibrillation treatment right the first time
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 18:52 CET
You may be interested in
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025
thumbnail
Congress Presentation
Pulmonary vein isolation using Cryo Balloon ablation versus RF ablation using ablation index following the CLOSE protocol: a Prospective Randomized Trial
23 April 2021
thumbnail
Congress Presentation
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.
25 August 2023
thumbnail
Congress Session
PFA technologies: balloon-in-basket and dual energy
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources